Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 4Recruiting 3Withdrawn 2Unknown 2Terminated 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Other 1Gynecologic 1

Conditions

Prostatic Neoplasms 2Sexual Dysfunction, Physiological 1

Interventions

Docetaxel 33Radiosurgery 23Radiotherapy 21Sunitinib 20pembrolizumab 18Gemcitabine 16Cisplatin 16Androgen Antagonists 15Nivolumab 14enzalutamide 13Goserelin 13Prednisone 12Leuprolide 12Blood Specimen Collection 12Abiraterone Acetate 12bicalutamide 11aldesleukin 11Surveys and Questionnaires 11Cyclophosphamide 11Gonadotropin-Releasing Hormone 10Bevacizumab 10Multiparametric Magnetic Resonance Imaging 9Carboplatin 9acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 8Triptorelin Pamoate 8Radiotherapy, Intensity-Modulated 8Filgrastim 8Epirubicin 8Chemotherapy, Adjuvant 8Brachytherapy 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × High-Intensity Focused Ultrasound Ablation × Genitourinary × Clear all
NCT00987675 2013-08-26

High-Intensity Focused Ultrasound Ablation in Treating Patients With Progressive Prostate Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
26 enrolled
Genitourinary

Prostatic Neoplasms

NCT00988130 2013-08-26

High-Intensity Focused Ultrasound Focal Ablation in Treating Patients With Progressive Prostate Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
26 enrolled
GenitourinaryOther

Prostatic Neoplasms, Sexual Dysfunction, Physiological

Data powered by HemOnc (CC BY 4.0) Colophon âš¡